Selenium nanoparticles trigger alterations in ovarian cancer cell biomechanics.

Abstract High dose selenium acts as a cytotoxic agent, with potential applications in cancer treatment. However, clinical trials have failed to show any chemotherapeutic value of selenium at safe and tolerated doses (